(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(0.12%) $82.73
(0.94%) $2.05
(-0.43%) $2 347.50
(-0.80%) $27.44
(-0.16%) $960.00
(-0.22%) $0.933
(-0.35%) $10.99
(-0.54%) $0.796
(1.56%) $93.31
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 4.24%
-0.39% $ 239.93
Live Chart Being Loaded With Signals
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers...
Stats | |
---|---|
Tagesvolumen | 795 919 |
Durchschnittsvolumen | 1.26M |
Marktkapitalisierung | 47.86B |
EPS | $0 ( 2024-01-31 ) |
Nächstes Ertragsdatum | ( $3.65 ) 2024-05-01 |
Last Dividend | $0.510 ( 2024-02-08 ) |
Next Dividend | $0 ( N/A ) |
P/E | 26.14 |
ATR14 | $0.0800 (0.03%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Mauch Robert P. | Buy | 33 877 | Common Stock |
2024-04-15 | Mauch Robert P. | Sell | 57 564 | Common Stock |
2024-04-15 | Mauch Robert P. | Sell | 33 877 | Non-qualified Stock Option (Right to Buy) |
2024-04-16 | Collis Steven H | Buy | 10 754 | Common Stock |
2024-04-16 | Collis Steven H | Sell | 10 754 | Common Stock |
INSIDER POWER |
---|
-94.99 |
Last 100 transactions |
Buy: 2 604 382 | Sell: 9 509 482 |
Volumen Korrelation
CoreSite Realty Corp Korrelation
10 Am meisten positiv korreliert | |
---|---|
AMAM | 0.924 |
ELF | 0.919 |
SLQT | 0.918 |
TDC | 0.915 |
KDMN | 0.915 |
ZGN | 0.909 |
GWW | 0.909 |
CTLT | 0.909 |
MOG-B | 0.907 |
NEWR | 0.904 |
10 Am meisten negativ korreliert | |
---|---|
AVYA | -0.957 |
ATTO | -0.955 |
FPI | -0.946 |
KT | -0.945 |
EQC | -0.944 |
GEO | -0.944 |
A | -0.932 |
DHX | -0.931 |
QGEN | -0.93 |
WRBY | -0.925 |
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
CoreSite Realty Corp Korrelation - Währung/Rohstoff
CoreSite Realty Corp Finanzdaten
Annual | 2023 |
Umsatz: | $262.17B |
Bruttogewinn: | $8.96B (3.42 %) |
EPS: | $8.62 |
FY | 2023 |
Umsatz: | $262.17B |
Bruttogewinn: | $8.96B (3.42 %) |
EPS: | $8.62 |
FY | 2022 |
Umsatz: | $238.59B |
Bruttogewinn: | $8.33B (3.49 %) |
EPS: | $8.15 |
FY | 2020 |
Umsatz: | $606.82M |
Bruttogewinn: | $412.97M (68.05 %) |
EPS: | $1.960 |
Financial Reports:
No articles found.
CoreSite Realty Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.460 (N/A) |
$0.485 (N/A) |
$0.485 (N/A) |
$0.485 (N/A) |
$0.485 (N/A) |
$0.510 (N/A) |
$0.510 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.00625 | 2001-11-15 |
Last Dividend | $0.510 | 2024-02-08 |
Next Dividend | $0 | N/A |
Payout Date | 2024-02-26 | |
Next Payout Date | N/A | |
# dividends | 137 | -- |
Total Paid Out | $51.69 | -- |
Avg. Dividend % Per Year | 2.24% | -- |
Score | 5.48 | -- |
Div. Sustainability Score | 7.90 | |
Div.Growth Potential Score | 5.97 | |
Div. Directional Score | 6.94 | -- |
Year | Amount | Yield |
---|---|---|
2001 | $0.00625 | 0.05% |
2002 | $0.0250 | 0.16% |
2003 | $0.0250 | 0.17% |
2004 | $0.0250 | 0.19% |
2005 | $0.0313 | 0.22% |
2006 | $0.0625 | 0.30% |
2007 | $0.812 | 3.52% |
2008 | $0.163 | 0.73% |
2009 | $0.240 | 1.35% |
2010 | $0.500 | 1.88% |
2011 | $1.060 | 3.09% |
2012 | $1.410 | 3.70% |
2013 | $2.03 | 4.66% |
2014 | $2.47 | 3.53% |
2015 | $3.00 | 3.32% |
2016 | $3.78 | 3.71% |
2017 | $5.06 | 6.12% |
2018 | $5.68 | 6.04% |
2019 | $6.36 | 8.54% |
2020 | $7.81 | 9.18% |
2021 | $6.82 | 7.07% |
2022 | $1.865 | 1.41% |
2023 | $1.965 | 1.20% |
2024 | $0.510 | 0.25% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
NCZ | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.79% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00687 | 1.500 | 9.86 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0289 | 1.200 | 9.04 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 2.48 | 1.500 | 10.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.217 | -1.000 | 7.83 | -7.83 | [0 - 1] |
currentRatioTTM | 0.884 | 0.800 | -0.582 | -0.466 | [1 - 3] |
quickRatioTTM | 0.484 | 0.800 | -1.859 | -1.487 | [0.8 - 2.5] |
cashRatioTTM | 0.0585 | 1.500 | -0.786 | -1.179 | [0.2 - 2] |
debtRatioTTM | 0.0739 | -1.500 | 8.77 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 10.18 | 1.000 | 7.34 | 7.34 | [3 - 30] |
operatingCashFlowPerShareTTM | 20.42 | 2.00 | 3.19 | 6.38 | [0 - 30] |
freeCashFlowPerShareTTM | 18.14 | 2.00 | 0.930 | 1.860 | [0 - 20] |
debtEquityRatioTTM | 5.24 | -1.500 | 10.00 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0330 | 1.000 | -2.78 | -2.78 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.00905 | 1.000 | -1.819 | -1.819 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.855 | 1.000 | 6.36 | 6.36 | [0.2 - 2] |
assetTurnoverTTM | 4.20 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 7.90 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 25.81 | 1.000 | 7.49 | 0 | [1 - 100] |
returnOnEquityTTM | 2.48 | 2.50 | 10.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 18.14 | 2.00 | 3.95 | 1.860 | [0 - 30] |
dividendYielPercentageTTM | 0.826 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 20.42 | 2.00 | 3.19 | 6.38 | [0 - 30] |
payoutRatioTTM | 0.217 | 1.500 | 7.83 | -7.83 | [0 - 1] |
pegRatioTTM | 3.19 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0150 | 1.000 | -2.12 | 0 | [0.1 - 0.5] |
Total Score | 5.97 |
CoreSite Realty Corp
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.